0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Upstream Bioprocessing Market by Product, Workflow, Use Type, Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5612832
UP TO EUR$697USDGBP OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Upstream Bioprocessing Market grew from USD 10.70 billion in 2023 to USD 12.09 billion in 2024. It is expected to continue growing at a CAGR of 13.54%, reaching USD 26.03 billion by 2030.

Upstream bioprocessing involves the initial stages of the biomanufacturing process, which includes cell line development, culture media preparation, and the growing of cells in bioreactors. Its necessity stems from the critical role it plays in producing biologics, such as vaccines, antibodies, and recombinant proteins, which are essential in healthcare and biotechnology industries. The application of upstream bioprocessing is wide-ranging, including pharmaceuticals, research applications, and food and agriculture sectors. The end-use scope extends to academic research institutions, biopharmaceutical companies, and contract manufacturing organizations. Key influencing growth factors include a surge in demand for biological products, technological advancements in bioreactor designs, and increased investment in biopharmaceutical R&D. Potential opportunities lie in the development of single-use technologies and automation to enhance efficiency, and in exploring sustainable practices to reduce environmental impact. To capitalize on these opportunities, companies should invest in innovative bioprocessing solutions and form strategic partnerships for technological advancements. However, the market faces limitations such as high initial costs, process complexity, and stringent regulatory environments which can hinder growth; competition from well-established traditional pharmaceuticals also presents a challenge. Areas ripe for innovation include the development of hybrid systems integrating AI and IoT for process optimization, and refining culture media compositions to boost yield and quality. The future nature of the market is likely to be characterized by a shift towards personalized medicine production, thereby necessitating agility and customization in upstream processes. Emphasizing advancement in cell culture techniques and scalable production models will be crucial for businesses to maintain competitiveness in this evolving landscape. To thrive, firms should focus on collaborative research and dynamic adaptation to regulatory changes, along with continuous enhancement of their technological capabilities.

Understanding Market Dynamics in the Upstream Bioprocessing Market

The Upstream Bioprocessing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising demand for biotherapeutics
    • Growing implementation of process analytical technology (PAT)
    • Rapid adoption of single-use upstream bioprocessing
  • Market Restraints
    • High cost of establishing and maintaining an upstream processing unit
  • Market Opportunities
    • Increased acceptance and approvals of biosimilars
    • Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
  • Market Challenges
    • Limitations to its capabilities related to standard upstream bioprocess monitoring

Exploring Porter’s Five Forces for the Upstream Bioprocessing Market

Porter’s Five Forces framework further strengthens the insights of the Upstream Bioprocessing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Upstream Bioprocessing Market

External macro-environmental factors deeply influence the performance of the Upstream Bioprocessing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Upstream Bioprocessing Market

The Upstream Bioprocessing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Upstream Bioprocessing Market

The Upstream Bioprocessing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Upstream Bioprocessing Market

The Upstream Bioprocessing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Upstream Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Boehringer Ingelheim International GmbH, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd, GE Healthcare, Getinge AB, High Purity New England, Lonza Group AG, Meissner Filtration Products, Inc.,, Merck KGaA, Rentschler Biopharma SE, Samsung BioLogics, Sartorius AG, Tornado Spectral Systems, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Upstream Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Bags & Containers
    • Bioreactors & Fermenters
    • Bioreactors Accessories
    • Cell Culture Products
    • Filters
  • Workflow
    • Cell Culture
    • Cell Separation
    • Media Preparation
  • Use Type
    • Multi-Use
    • Single-Use
  • Mode
    • In-House
    • Outsourced
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for biotherapeutics
5.1.1.2. Growing implementation of process analytical technology (PAT)
5.1.1.3. Rapid adoption of single-use upstream bioprocessing
5.1.2. Restraints
5.1.2.1. High cost of establishing and maintaining an upstream processing unit
5.1.3. Opportunities
5.1.3.1. Increased acceptance and approvals of biosimilars
5.1.3.2. Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
5.1.4. Challenges
5.1.4.1. Limitations to its capabilities related to standard upstream bioprocess monitoring
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Upstream Bioprocessing Market, by Product
6.1. Introduction
6.2. Bags & Containers
6.3. Bioreactors & Fermenters
6.4. Bioreactors Accessories
6.5. Cell Culture Products
6.6. Filters
7. Upstream Bioprocessing Market, by Workflow
7.1. Introduction
7.2. Cell Culture
7.3. Cell Separation
7.4. Media Preparation
8. Upstream Bioprocessing Market, by Use Type
8.1. Introduction
8.2. Multi-Use
8.3. Single-Use
9. Upstream Bioprocessing Market, by Mode
9.1. Introduction
9.2. In-House
9.3. Outsourced
10. Americas Upstream Bioprocessing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Upstream Bioprocessing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Upstream Bioprocessing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. UPSTREAM BIOPROCESSING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. UPSTREAM BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. UPSTREAM BIOPROCESSING MARKET DYNAMICS
TABLE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS & FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 36. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 38. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 42. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 58. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 60. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 62. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 64. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 72. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 96. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 109. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 113. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 117. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 121. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 125. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 131. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 133. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 145. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 147. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 149. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 151. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 153. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 169. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 181. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 191. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Upstream Bioprocessing Market, which are profiled in this report, include:
  • Boehringer Ingelheim International GmbH
  • Danaher Corporation
  • Eppendorf AG
  • Esco Micro Pte. Ltd
  • GE Healthcare
  • Getinge AB
  • High Purity New England
  • Lonza Group AG
  • Meissner Filtration Products, Inc.,
  • Merck KGaA
  • Rentschler Biopharma SE
  • Samsung BioLogics
  • Sartorius AG
  • Tornado Spectral Systems
  • Waters Corporation

Methodology

Table Information